Resideo Technologies introduced Pro-IQ Predict, an AI-driven service integrated with Honeywell Home smart thermostats that detects over 80 HVAC system issues early. This predictive technology alerts HVAC contractors to potential problems, enabling proactive maintenance and reducing emergency repairs. The service enhances home comfort by preventing unexpected system failures and is available via software updates to existing Pro-IQ subscribers. Homeowners can connect with local HVAC professionals for this service through HoneywellHome.com.
Resideo Technologies' launch of Pro-IQ Predict offers a new AI-powered tool for HVAC predictive maintenance. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Nov 10, 2026 17:41 WIB: of 134 priced US stocks, 71 rose and 54 fell. Notable movers include SE (Sea Limited) at USD 78.85 with a 1-day change of +1.14% and a typical hold time of 104 days, UAA (Under Armour Inc Class A) at USD 5.52 up +1.10%, and GLBE (Global E Online Ltd) at USD 42.90 up +0.96%.
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
ESET Research uncovered a sophisticated cyberespionage tool named Cereal, used by the Russia-aligned Turla group to spy on emails within Microsoft Exchange servers of governmental organizations in Kazakhstan and Romania. The tool stealthily collects ...
The global paracetamol market is projected to grow from $12.05 billion in 2026 to $15.39 billion by 2032, with a CAGR of 4.12%. Growth is driven by increasing demand for pain and fever management, expanded access to over-the-counter medicines, and in...
Registration is now open for Brand Licensing Expo 2027, scheduled for May 25-27 at Mandalay Bay, Las Vegas. The event, rebranded from Licensing Expo, features over 265 confirmed exhibitors including major brands like Amazon MGM Studios, Coca-Cola, an...
Trogenix, a clinical-stage precision oncology company, has appointed John Young as Chair and Josh Murray as Non-Executive Director to support its global strategy, commercial growth, and US expansion. John Young brings over 35 years of pharmaceutical ...
